Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We used a propagation-defective, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the hemagglutinin (HA) and neuraminidase (NA) proteins from influenza A/Wyoming/03/2003 (H3N2). Efficient production methods were scaled to produce pilot lots of HA VRP and NA VRP and clinical lots of HA VRP. HA VRP-induced high-titered antibody responses in mice, rabbits and rhesus macaques, as measured by ELISA or hemagglutination inhibition (HI) assays, and robust cellular immune responses in mice and rhesus macaques, as measured by IFN-gamma ELISPOT. NA VRP also induced cellular immune responses in mice. A toxicology study with HA VRP and NA VRP in rabbits showed no adverse effects in any parameter. These studies support clinical testing of alphavirus replicon vaccines for influenza.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706696PMC
http://dx.doi.org/10.1016/j.vaccine.2007.09.038DOI Listing

Publication Analysis

Top Keywords

alphavirus replicon
12
responses mice
12
lots vrp
8
vrp vrp
8
rhesus macaques
8
macaques measured
8
cellular immune
8
immune responses
8
vrp
7
development preclinical
4

Similar Publications

Increasing Occurrence of Marburg Virus Outbreaks in Africa: Risk Assessment for Public Health.

Microb Biotechnol

September 2025

KU Leuven, Department of Biosystems, Laboratory of Gene Technology, Leuven, Belgium.

In this millennium, Marburgvirus (MARV) outbreaks with very high mortality but still small case numbers (< 400) were observed with increasing frequency in Africa. Ecologists identified Egyptian Rousettus bats (ERB) as viral reservoir species causing occasional zoonotic spillover events, mostly in humans intruding into their cave habitats as miners or tourists. So far only short human-to-human transmission chains have been documented.

View Article and Find Full Text PDF

Small nucleolar RNAs (snoRNAs) are prevailing components of the chromatin-associated transcriptome. Here we show that specific snoRNAs are required for the activation of immune response genes and for survival during viral infections in Drosophila melanogaster. We have studied snoRNA:U3:9B, a chromatin-associated snoRNA that binds to a large number of protein coding genes, including immune response genes.

View Article and Find Full Text PDF

A number of different vaccines against feline leukemia virus (FeLV) are available; however, there is continuous debate regarding the efficacy advantages of adjuvanted vaccines versus the potential safety advantages of non-adjuvanted vaccines. For this reason, we developed a non-adjuvanted vaccine based on a replicon RNA particle (RP) expressing the FeLV gp85 envelope protein, which possesses the safety of a non-adjuvanted vaccine while consistently providing high efficacy. In two efficacy studies, a high-level of protection against virulent FeLV challenge was demonstrated with two doses given 3 weeks apart based on the prevention of FeLV p27 antigenemia.

View Article and Find Full Text PDF

Improvement in the potency of a N-methylpseudouridine-modified self-amplifying RNA through mutations in the RNA-dependent RNA polymerase.

J Biol Chem

August 2025

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín-CONICET, Argentina. Electronic address:

mRNA technology has widely incorporated modified nucleotides to temper innate immune activation by foreign RNA and achieve high levels of heterologous protein expression. However, the incorporation of modified nucleotides has had limited application to self-amplifying (sa) RNAs, as it impeded heterologous protein expression. Here, we used a reporter replicon of the attenuated TC-83 strain of Venezuelan equine encephalitis virus (VEEV) to investigate the impact of modified nucleotide incorporation on the replication capacity of the saRNA in transfected cells.

View Article and Find Full Text PDF

Chlorinated biscoumarins inhibit chikungunya virus replication in cell-based and animal models.

Emerg Microbes Infect

December 2025

Center of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Biscoumarin derivatives were evaluated for antiviral activity against chikungunya virus (CHIKV), a re-emerging mosquito-borne alphavirus with no approved treatment. Compounds 3 and 4 demonstrated potent antiviral efficacy, with EC₅₀ values of 2.85 ± 0.

View Article and Find Full Text PDF